NRD
BIIB icon

Nebula Research & Development’s Biogen BIIB Stock Holding History

Nebula Research & Development’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-4,700
Closed -$1.01M – 809
2024
Q1 		$1.01M Buy
+4,700
New +$1.1M 0.22% 139

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Nebula Research & Development's BIIB Position: Q2 2024 in Review

Nebula Research & Development sold out of Biogen (BIIB) in Q2 2024, closing a stake of 4,700 shares — an estimated $1.01M sold.

Nebula Research & Development first reported a position in BIIB in Q1 2024 and held it in 1 quarter. The position peaked at $1.01M in Q1 2024. 943 funds tracked by Wall St. Rank hold BIIB as of Q2 2024.

  • Nebula Research & Development reported no remaining Biogen position as of Q2 2024 after selling out during the quarter.
  • Nebula Research & Development sold 4,700 Biogen shares in Q2 2024, an estimated $1.01M.
  • Nebula Research & Development first reported a position in Biogen in Q1 2024 and held it in 1 quarter.
  • Nebula Research & Development's Biogen position peaked at $1.01M in Q1 2024.
  • 943 funds tracked by Wall St. Rank held Biogen as of Q2 2024.

Based on Nebula Research & Development's 13F filing for Q2 2024, filed 14 Aug 2024.